首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2019年 6期 HBV cccDNA研究进展 => 肝脏肿瘤 =>ECEL1基因PSC..
ECEL1基因PSCSI-GFP慢病毒载体的构建
Construction of PSCSI-GFP lentiviral vector for the endothelin-converting enzyme-like 1 gene
文章发布日期:2019年05月13日  来源:  作者:何剑,廖红伍,阳学风  点击次数:204次  下载次数:41次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:目的设计并构建针对ECEL1基因的RNA干扰慢病毒载体。方法依照ECEL1基因为模板,设计RNA干扰靶点,根据选定的靶点序列,设计短发夹RNA(shRNA)干扰序列,在两端添加相应的限制性内切酶酶切位点,合成单链DNA oligo,退火缓冲液中配对形成双链DNA oligo 。利用Age I和EcoR I双酶线性化GV115载体。把载体和DNA oligo相连接,其连接产物转化大肠杆菌感受态细胞,经PCR扩增并测序鉴定。再通过质粒抽提,转染,浓缩与纯化后获得重组的ECEL1基因RNAi慢病毒,用“HIV-1 p24 抗原 ELISA法”测定样品滴度。选取检测合格的慢病毒感染人肝癌细胞(BEL-7404),并设置对照组,荧光观察感染率。并使用Real-time PCR法及Western blot检测人肝癌细胞(BEL-7404)中ECEL1基因敲减后mRNA和蛋白质的表达量。2组间比较采用两独立样本t检验。结果(1)根据ECEL1基因模板设计后,选定psc48784片段作为RNA干扰靶点,制备双链DNA oligo,PCR鉴定阳性重组子并测序,验证psc48784为正确的克隆。经过质粒抽提,转染以及浓缩纯化后,成功构建ECEL1基因RNAi慢病毒。物理检测与无菌检测合格。(2)通过HIV-1 p24 抗原 ELISA 法测定ECEL1基因RNAi慢病毒样品病毒滴,测定样品病毒滴度为3×108 TU/ml;表明已成功构建高滴度且合格的ECEL1基因RNA干扰慢病毒。(3)用ECEL1基因RNAi慢病毒感染人肝癌细胞(BEL-7404),荧光观察结果显示细胞感染效率达到80%,细胞状态稳定;使用Real-time PCR的方法及Western blot检测实验组人肝癌细胞(BEL-7404)中ECEL1基因在mRNA和蛋白质水平的表达量受到抑制(P值均<0.05),敲减效率达到70.5%。结论成功构建ECEL1基因PSCSI-GFP 慢病毒载体并获得稳定高滴度的病毒样品,并获得稳定的ECEL1基因敲减的人肝癌细胞(BEL-7404)。
【Abstract】:ObjectiveTo design and construct the RNA interference (RNAi) lentiviral vector targeting the endothelin-converting enzyme-like 1 (ECEL1) gene. MethodsThe RNA interference target was designed with the ECEL1 gene as the template, and the short-hairpin RNA (shRNA) interference sequence was designed based on the selected target sequence. Enzyme cut sites for restriction endonuclease were added to both ends of this sequence to synthesize single-stranded DNA oligo, which was then paired in annealing buffer to form double-stranded DNA oligo. GV115 vectors were linearized by double digestion with Age I and EcoR I enzymes, and then they were connected with the DNA oligo; the grafted product transformed Escherichia coli receptor cells and was amplified, sequenced, and identified by PCR. The recombinant ECEL1 gene RNAi lentivirus was obtained by plasmid extraction, transfection, concentration, and purification, and HIV-1 p24 antigen ELISA was used to determine the titer of the recombinant RNAi lentivirus. Human hepatoma BEL-7404 cells were transfected with the qualified lentivirus, and a control group was set up. Fluorescence observation was performed to determine transfection rate. Real-time PCR and Western blot were used to measure the mRNA and protein expression of target gene after ECEL1 gene knockdown in human hepatoma BEL-7404 cells. The two-independent-samples t test was used for comparison between two groups. ResultsAfter the design with the ECEL1 gene as the template, the psc48784 fragment was selected as the target for RNAi; the double-stranded DNA oligo was prepared and the positive recons were identified and sequenced by PCR, and the results showed that psc48784 was the correct clone. The ECEL1 gene RNAi lentivirus was successfully constructed after plasmid extraction, transfection, concentration, and purification and was qualified for physical test and sterility test. HIV-1 p24 antigen ELISA showed that the ECEL1 gene RNAi lentivirus had a virus titer of 3E+8 TU/ml, suggesting that the qualified ECEL1 gene RNAi lentivirus with a high titer was successfully constructed. After the human hepatoma BEL-7404 cells were transfected with the ECEL1 gene RNAi lentivirus, fluorescence observation showed a transfection efficiency of 80% and a stable state of cells. Real-time PCR and Western blot showed significant reductions in the mRNA and protein expression of the ECEL1 gene in human hepatoma BEL-7404 cells in the experimental group (P<0.05), and the knockdown efficiency reached 70.5%. ConclusionThe ECEL1 gene PSCSI-GFP lentiviral vector is successfully constructed, and stable virus samples with a high titer are obtained. The stable human hepatoma BEL-7404 cells with ECEL1 gene knockdown are also obtained.
【关键字】:ECEL1基因; 慢病毒载体; 肝肿瘤
【Key words】:ECEL1 gene; lentiviral vector; liver neoplasms
【引证本文】:HE J, LIAO HW, YANG XF. Construction of PSCSI-GFP lentiviral vector for the endothelin-converting enzyme-like 1 gene[J]. J Clin Hepatol, 2019, 35(6): 1286-1292. (in Chinese)
何剑, 廖红伍, 阳学风. ECEL1基因PSCSI-GFP慢病毒载体的构建[J]. 临床肝胆病杂志, 2019, 35(6): 1286-1292.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号